- Home
- OFLX vs TNGX Comparison
OFLX vs TNGX Comparison
Compare OFLX & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFLX
- TNGX
- Stock Information
- Founded
- OFLX 1975
- TNGX 2014
- Country
- OFLX United States
- TNGX United States
- Employees
- OFLX N/A
- TNGX N/A
- Industry
- OFLX Industrial Specialties
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- OFLX Industrials
- TNGX Health Care
- Exchange
- OFLX Nasdaq
- TNGX Nasdaq
- Market Cap
- OFLX 374.3M
- TNGX 317.4M
- IPO Year
- OFLX 2005
- TNGX N/A
- Fundamental
- Price
- OFLX $29.20
- TNGX $1.29
- Analyst Decision
- OFLX
- TNGX Strong Buy
- Analyst Count
- OFLX 0
- TNGX 7
- Target Price
- OFLX N/A
- TNGX $12.33
- AVG Volume (30 Days)
- OFLX 31.1K
- TNGX 756.3K
- Earning Date
- OFLX 04-30-2025
- TNGX 05-07-2025
- Dividend Yield
- OFLX 4.63%
- TNGX N/A
- EPS Growth
- OFLX N/A
- TNGX N/A
- EPS
- OFLX 1.78
- TNGX N/A
- Revenue
- OFLX $101,681,000.00
- TNGX $42,069,000.00
- Revenue This Year
- OFLX N/A
- TNGX N/A
- Revenue Next Year
- OFLX N/A
- TNGX N/A
- P/E Ratio
- OFLX $16.36
- TNGX N/A
- Revenue Growth
- OFLX N/A
- TNGX 15.17
- 52 Week Low
- OFLX $29.04
- TNGX $1.11
- 52 Week High
- OFLX $68.50
- TNGX $12.02
- Technical
- Relative Strength Index (RSI)
- OFLX 24.42
- TNGX 37.63
- Support Level
- OFLX $29.47
- TNGX $1.25
- Resistance Level
- OFLX $31.14
- TNGX $1.44
- Average True Range (ATR)
- OFLX 1.55
- TNGX 0.15
- MACD
- OFLX -0.33
- TNGX 0.03
- Stochastic Oscillator
- OFLX 2.44
- TNGX 45.00
About OFLX Omega Flex Inc.
Omega Flex Inc is a manufacturer of flexible metal hoses, which is used in a variety of ways to carry gases and liquids within their particular applications. Omega sells its products under the TracPipe, CounterStrike, DoubleTrac, DEF-Trac and MediTrac brands. It serves various markets which include construction, manufacturing, transportation, petrochemical, pharmaceutical, and other industries. Geographically Omega Flex, Inc operates in the United States.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.